These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 18571782)

  • 41. Prion protein amyloidosis.
    Ghetti B; Piccardo P; Frangione B; Bugiani O; Giaccone G; Young K; Prelli F; Farlow MR; Dlouhy SR; Tagliavini F
    Brain Pathol; 1996 Apr; 6(2):127-45. PubMed ID: 8737929
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increased immunohistochemical labelling for prion protein occurs in diverse neurological disorders of sheep: relevance for normal cellular PrP function.
    Jeffrey M; Scholes SF; Martin S; McGovern G; Sisó S; González L
    J Comp Pathol; 2012 Jul; 147(1):46-54. PubMed ID: 22000036
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rapidly progressive dementia with thalamic degeneration and peculiar cortical prion protein immunoreactivity, but absence of proteinase K resistant PrP: a new disease entity?
    Kovacs GG; Peden A; Weis S; Höftberger R; Berghoff AS; Yull H; Ströbel T; Koppi S; Katzenschlager R; Langenscheidt D; Assar H; Zaruba E; Gröner A; Voigtländer T; Puska G; Hametner E; Grams A; Muigg A; Knoflach M; László L; Ironside JW; Head MW; Budka H
    Acta Neuropathol Commun; 2013 Nov; 1():72. PubMed ID: 24252716
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A brain aggregate model gives new insights into the pathobiology and treatment of prion diseases.
    Bajsarowicz K; Ahn M; Ackerman L; Dearmond BN; Carlson G; DeArmond SJ
    J Neuropathol Exp Neurol; 2012 May; 71(5):449-66. PubMed ID: 22507918
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A transgenic model of a familial prion disease.
    Harris DA; Chiesa R; Drisaldi B; Quaglio E; Migheli A; Piccardo P; Ghetti B
    Arch Virol Suppl; 2000; (16):103-12. PubMed ID: 11214912
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Atypical prion protein conformation in familial prion disease with PRNP P105T mutation.
    Polymenidou M; Prokop S; Jung HH; Hewer E; Peretz D; Moos R; Tolnay M; Aguzzi A
    Brain Pathol; 2011 Mar; 21(2):209-14. PubMed ID: 20875062
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In situ formation of protease-resistant prion protein in transmissible spongiform encephalopathy-infected brain slices.
    Bessen RA; Raymond GJ; Caughey B
    J Biol Chem; 1997 Jun; 272(24):15227-31. PubMed ID: 9182546
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Medicine. In a first, infected mice recover from prion disease.
    Couzin J
    Science; 2003 Oct; 302(5646):763-5. PubMed ID: 14593140
    [No Abstract]   [Full Text] [Related]  

  • 49. The Size and Stability of Infectious Prion Aggregates Fluctuate Dynamically during Cellular Uptake and Disaggregation.
    Shoup D; Priola SA
    Biochemistry; 2021 Feb; 60(5):398-411. PubMed ID: 33497187
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Distinct stability states of disease-associated human prion protein identified by conformation-dependent immunoassay.
    Choi YP; Peden AH; Gröner A; Ironside JW; Head MW
    J Virol; 2010 Nov; 84(22):12030-8. PubMed ID: 20844046
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Proteomic analysis of prion diseases: creating clarity or causing confusion?
    Rubenstein R
    Electrophoresis; 2012 Dec; 33(24):3631-43. PubMed ID: 23161058
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fundamentals of prion biology and diseases.
    DeArmond SJ; Bouzamondo E
    Toxicology; 2002 Dec; 181-182():9-16. PubMed ID: 12505278
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anchorless prion protein results in infectious amyloid disease without clinical scrapie.
    Chesebro B; Trifilo M; Race R; Meade-White K; Teng C; LaCasse R; Raymond L; Favara C; Baron G; Priola S; Caughey B; Masliah E; Oldstone M
    Science; 2005 Jun; 308(5727):1435-9. PubMed ID: 15933194
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Recombinant human prion protein fragment 90-231, a useful model to study prion neurotoxicity.
    Corsaro A; Thellung S; Villa V; Nizzari M; Aceto A; Florio T
    OMICS; 2012; 16(1-2):50-9. PubMed ID: 22321015
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prion protein on astrocytes or in extracellular fluid impedes neurodegeneration induced by truncated prion protein.
    Race B; Meade-White K; Race R; Baumann F; Aguzzi A; Chesebro B
    Exp Neurol; 2009 Jun; 217(2):347-52. PubMed ID: 19332059
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of cryptic nuclear localization signals in the prion protein.
    Gu Y; Hinnerwisch J; Fredricks R; Kalepu S; Mishra RS; Singh N
    Neurobiol Dis; 2003 Mar; 12(2):133-49. PubMed ID: 12667468
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cerebral amyloid in human prion disease.
    Watanabe R; Duchen LW
    Neuropathol Appl Neurobiol; 1993 Jun; 19(3):253-60. PubMed ID: 8355811
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lack of TAR-DNA binding protein-43 (TDP-43) pathology in human prion diseases.
    Isaacs AM; Powell C; Webb TE; Linehan JM; Collinge J; Brandner S
    Neuropathol Appl Neurobiol; 2008 Aug; 34(4):446-56. PubMed ID: 18657254
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Phenotypic variability in the brains of a family with a prion disease characterized by a 144-base pair insertion in the prion protein gene.
    King A; Doey L; Rossor M; Mead S; Collinge J; Lantos P
    Neuropathol Appl Neurobiol; 2003 Apr; 29(2):98-105. PubMed ID: 12662318
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular mechanisms of neurotoxicity of pathological prion protein.
    Castilla J; Hetz C; Soto C
    Curr Mol Med; 2004 Jun; 4(4):397-403. PubMed ID: 15354870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.